Awarded as the leading service provider for the pharmaceutical and biotech industry

The Vetter team with Managing Director Peter Sölkner (second from the left) is proud to accept the CDMO Leadership Awards 2024 for the company. © Vetter Pharma International GmbH

– Prestigious awards in all six main categories
– Vetter offers customers the highest quality and value creation
– Revenue result 2023 demonstrates sustained sustainable growth

Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), was once again recognized in all six main categories—Quality, Expertise, Reliability, Portfolio, Compatibility, and Service—at the 13th CDMO Leadership Awards 2024, receiving the highest ratings across all survey groups. The award affirms the company's commitment to providing its pharmaceutical and biotech customers worldwide with the highest quality and optimal value in the development, manufacturing, assembly, and packaging of injectables.

This outstanding achievement is also reflected in the revenue of 1,002 million euros in the fiscal year 2023, with Vetter surpassing the billion-euro mark for the first time. This success underscores a clear commitment to long-term customer relationships and sustainable growth.

“The repeated recognition with the CDMO Leadership Awards is proof that we bring our corporate mission to life in our daily work,” says Vetter Managing Director Peter Sölkner. “We therefore aim to maintain the high standards expressed by this award, entirely in the spirit of our customers and their patients. We rely on the decades of experience and expertise of our 6,300 employees to do so.”

The CDMO Leadership Awards have been presented for 13 years by Outsourced Pharma and Life Science Leader, providing industry decision-makers with a solid and reliable aid in selecting potential development, manufacturing, and packaging partners. The award signifies a high level of performance in the key criteria of the main categories: winners are determined based on recent customer evaluations from the past 18 months of collaboration.

“Outsourcing partners are becoming increasingly important for pharmaceutical manufacturers. They contribute to stable supply chains and offer a technologically modern infrastructure as well as efficient proven processes. The CDMO Leadership Awards reflect our commitment to being the preferred partner for our customers in these challenges,” says Vetter Managing Director Thomas Otto. “We are proud that these awards further strengthen the trust in our quality and reliability.”

Louis Garguilo, Chief Editor and Conference Chair of Outsourced Pharma, adds: “Pharmaceutical service providers have faced many challenges over the past 12 months: insecure supply chains, new technology platforms and processes requiring new skills and technologies, and an industry that is changing faster and faster. Those who perform best for their customers and ultimately for patients worldwide are rightly awarded the CDMO Leadership Awards 2024.”